Nine-pharma sodium sodium sodium poop intestinal tablets were evaluated for consistency by generic drug.

Guide: This is the second enterprise in China to evaluate the consistency of sodium sodium sodium solute tablets in the country.
Hunan Jiuxian Pharmaceutical Co., Ltd. recently received the approval of the State Drug Administration issued by the "Drug Supplement Application Approval Notice", the company's products "sodium poise" through the quality and efficacy of generic drug consistency evaluation.
is a third-generation new type of proton pump inhibitor, mainly used to treat duodenal ulcers, stomach ulcers, moderate and severe reflux esophagitis, with kramycin and amoxicillin, or kramycin and metformin, or amoxicillin and metriceazole can be used to eradicate Helicobacter pylori infection.
the sodium sodium intestinal tablets were first developed by Byd Gulden in Germany and first listed in Germany in 1994, with a product called Pantoloc ®.
China has been successfully imitation in 1998, and has approved the raw materials of sodium cesiumazole, intestinal tablets, intestinal lysis, injections and other dosage forms on the market.
this is the second enterprise in China to evaluate the consistency of sodium sodium sodium sodium tablets in the country.
.